NTCP model for hypothyroidism after supraclavicular-directed radiation therapy for breast cancer

Breast cancer is the most common malignancy among women and second most common in the world, with approximately 1.67 million new cases diagnosed and half a million deaths worldwide in 2012 [1]. The standard treatment regimen for breast cancer varies based on stage and clinical presentation, but typically involves surgery, radiation therapy (RT), and systemic therapy. For patients at high-risk for locoregional recurrence, including those with axillary lymph node involvement, RT involving the breast (or chest wall in the case of post-mastectomy RT) and regional lymph nodes has been demonstrated to decrease the local recurrence risk and improve long-term survival [2,3].

Source: Radiotherapy and Oncology - September 9, 2020 Category: Radiology Authors: Huakang Huang, John Roberson, Wei Hou, Kartik Mani, Edward Valentine, Samuel Ryu, Alexander Stessin Tags: Original Article Source Type: research